Exact Mass: 440.2787266
Exact Mass Matches: 440.2787266
Found 371 metabolites which its exact mass value is equals to given mass value 440.2787266
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tirofiban
C22H36N2O5S (440.23448060000004)
Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation. B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Dolichol phosphate
C25H45O4P (440.30553000000003)
COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Norverapamil
Norverapamil is a calcium channel blocker. It is the main active metabolite of verapamil. Verapamil (brand names: Isoptin, Verelan, Verelan PM, Calan, Bosoptin, Covera-HS) is an L-type calcium channel blocker of the phenylalkylamine class. It has been used in the treatment of hypertension, angina pectoris, cardiac arrhythmia, and most recently, cluster headaches. It is also an effective preventive medication for migraine. Verapamil has also been used as a vasodilator during cryopreservation of blood vessels. (Wikipedia) D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Bolegrevilol
Bolegrevilol is found in mushrooms. Bolegrevilol is isolated from Suillus grevillei (larch bolete). Isolated from Suillus grevillei (larch bolete). Bolegrevilol is found in mushrooms.
Suillin
Metabolite of Suillus subspecies 4-Acetoxy-3-geranylgeranyl-1,2-dihydroxybenzene is found in mushrooms. Suillin is found in mushrooms. Suillin is a metabolite of Suillus specie
13'-Carboxy-gamma-tocotrienol
13-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 13-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate. Gamma-tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. Gamma-tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. 13-carboxy-r-tocotrienol is a dehydrogenation carboxylate product of 13-hydroxy-r-tocotrienol by an unidentified microsomal enzyme(s) probably via an aldehyde intermediate
O-Desmethylverapamil (D-702)
O-Desmethylverapamil (D-702) is a metabolite of Verapamil. O-desmethylverapamil belongs to the family of Phenylbutylamines. These are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine.
O-Desmethylverapamil (D-703)
O-Desmethylverapamil (D-703) is only found in individuals that have used or taken Verapamil. O-Desmethylverapamil (D-703) is a metabolite of Verapamil. O-desmethylverapamil (d-703) belongs to the family of Phenylbutylamines. These are compounds containing a phenylbutylamine moiety, which consists of a phenyl group substituted at the fourth carbon by an butan-1-amine.
2-Acetoxy-3-geranylgeranyl-1,4-dihydroxybenzene
2-Acetoxy-3-geranylgeranyl-1,4-dihydroxybenzene is found in mushrooms. 2-Acetoxy-3-geranylgeranyl-1,4-dihydroxybenzene is isolated from Suillus granulatus (granulated bolete). Isolated from Suillus granulatus (granulated bolete). 2-Acetoxy-3-geranylgeranyl-1,4-dihydroxybenzene is found in mushrooms.
(5Z,7E)-(3S)-26,26,26-Trifluoro-27-nor-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol
(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
N-[1-[[5-(Diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methyl-2-(propanoylamino)pentanamide
C21H40N6O4 (440.31108800000004)
3-[2-[[(1S,2R,3S)-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
p-O-Desmethyl Verapamil
8beta,15-Dihydroxy-ent-labda-13E-ene-8-O-beta-xylopyranoside
Scoparic acid A
A diterpenoid isolated from Scoparia dulcis and has been shown to exhibit inhibitory activity against beta-glucuronidase from bovine liver.
linalool-beta-D-glucopyranoside-2O-acetate,6O-tiglate
1,3-dihydroxy-5-<16-(3,5-dihydroxyphenyl)-cis-8-hexadecenyl>benzene|1,3-dihydroxy-5-<16-(3,5-dihydroxyphenyl)hexadec-8(Z)-en-1-yl>benzene|1,3-dihydroxy-5-[16-(3,5-dihydroxyphenyl)hexadec-8(Z)-en-1-yl]benzene|5,5-[(8Z)-hexadec-8-ene-1,16-diyl]bisresorcinol
(2E,9Z,16E)-2-tetradeca-5c,12t-diene-8,10-diynyl-octadeca-2,9,16-triene-12,14-diyn-1-ol
N-(1-Propionyl-2-methylbutyl)-2-[2-[(hydroxycarbamoyl)methyl]heptanoyl]hexahydropyridazine-3-carboxamide
C22H40N4O5 (440.29985500000004)
(2E,6E,10E)-5-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-12-one
2,6-diheptyl-6-hydroxy-7-methoxy-dibenzofuran-3,4-dione|fordianaquinone A
2-Epimer-6-[(3,4-Dihydro-6-methoxy-2,8-dimethyl-2H-1-benzopyran-2-yl)methyl]-1,2,3,3alpha,7,7alpha-hexahydro-5-(2-hydroxy-2-methylpropyl)-3alpha,7alpha-dimethyl-4H-inden-4-one
bolegrevilol
1-methyl-2-oxocyclohex-3-en-1-yl (2Z)-{(7aR)-1-[(2S,3E)-5,6-dimethylhept-3-en-2-yl]octahydro-7a-methyl-5-oxo-4H-inden-4-ylidene}ethanoate|chaxine C|jiangxienone
18beta-succinyloxy-ent-labdan-8beta-ol-15-oic acid
2-methylgrebustol A|5,5-(6Z)-tetradec-6-ene-1,14-diylbis(2-methylbenzene-1,3-diol)
(3S,4R)-4-([(1S,4aR,6S,8aS)-decahydro-6-hydroxy-5,5,8a-trimethyl-2-methylidenenaphthalen-1-yl]-methoxy)-5-methoxy-3-(methoxycarbonyl)-5-oxopentanoic acid|cryptoporic acid J
(22R,25R)-23alpha-hydroxy-1,4-spirostadien-3,26-dione|indioside L
(14beta,22E)-9,14-dihydroxyergosta-4,7,22-triene-3,6-dione
1,3-di-O-acetyl-2-O-oleoylglycerol|1,3-diacetyl-2-oleoyl-glycerol|1,3-diacetyl-2-oleoylglycerol
8-[(5-carboxy-2,9-epoxy)benzyl]-2,5-dihydroxy-1,1,4a,7,8-pentamethyl-1,2,3,4,4a,6,7,8,9,10,10a-dodecahydrophenanthrene
rel-(3aR,5aR,6S,9S,10aR)-2,3,3a,4,5,5a,6,9,10,10a-decahydro-8-(hydroxymethyl)-1-(2-hydroxy-1-methylethyl)-3a,5a-dimethylcyclohept[e]indene-6,9-diol|scabronine H
4-carbamoyl-2-[(9Z,12Z)-15,16-dihydroxyoctadeca-9,12-dienoylamino]butyric acid
C23H40N2O6 (440.28862200000003)
(+/-)-communesin F|(-)-communesin F|communesin E|communesin F
C28H32N4O (440.25759819999996)
Norverapamil
D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Ala His Ile Thr
Ala His Leu Thr
Ala His Thr Ile
Ala His Thr Leu
Ala Ile His Thr
Ala Ile Thr His
Ala Leu His Thr
Ala Leu Thr His
Ala Thr His Ile
Ala Thr His Leu
Ala Thr Ile His
Ala Thr Leu His
His Ala Ile Thr
His Ala Leu Thr
His Ala Thr Ile
His Ala Thr Leu
His Ile Ala Thr
His Ile Thr Ala
His Leu Ala Thr
His Leu Thr Ala
His Ser Val Val
His Thr Ala Ile
His Thr Ala Leu
His Thr Ile Ala
His Thr Leu Ala
His Val Ser Val
His Val Val Ser
Ile Ala His Thr
Ile Ala Thr His
Ile His Ala Thr
Ile His Thr Ala
Ile Ile Pro Val
C22H40N4O5 (440.29985500000004)
Ile Ile Val Pro
C22H40N4O5 (440.29985500000004)
Ile Leu Pro Val
C22H40N4O5 (440.29985500000004)
Ile Leu Val Pro
C22H40N4O5 (440.29985500000004)
Ile Pro Ile Val
C22H40N4O5 (440.29985500000004)
Ile Pro Leu Val
C22H40N4O5 (440.29985500000004)
Ile Pro Val Ile
C22H40N4O5 (440.29985500000004)
Ile Pro Val Leu
C22H40N4O5 (440.29985500000004)
Ile Thr Ala His
Ile Thr His Ala
Ile Val Ile Pro
C22H40N4O5 (440.29985500000004)
Ile Val Leu Pro
C22H40N4O5 (440.29985500000004)
Ile Val Pro Ile
C22H40N4O5 (440.29985500000004)
Ile Val Pro Leu
C22H40N4O5 (440.29985500000004)
Leu Ala His Thr
Leu Ala Thr His
Leu His Ala Thr
Leu His Thr Ala
Leu Ile Pro Val
C22H40N4O5 (440.29985500000004)
Leu Ile Val Pro
C22H40N4O5 (440.29985500000004)
Leu Leu Pro Val
C22H40N4O5 (440.29985500000004)
Leu Leu Val Pro
C22H40N4O5 (440.29985500000004)
Leu Pro Ile Val
C22H40N4O5 (440.29985500000004)
Leu Pro Leu Val
C22H40N4O5 (440.29985500000004)
Leu Pro Val Ile
C22H40N4O5 (440.29985500000004)
Leu Pro Val Leu
C22H40N4O5 (440.29985500000004)
Leu Thr Ala His
Leu Thr His Ala
Leu Val Ile Pro
C22H40N4O5 (440.29985500000004)
Leu Val Leu Pro
C22H40N4O5 (440.29985500000004)
Leu Val Pro Ile
C22H40N4O5 (440.29985500000004)
Leu Val Pro Leu
C22H40N4O5 (440.29985500000004)
Pro Ile Ile Val
C22H40N4O5 (440.29985500000004)
Pro Ile Leu Val
C22H40N4O5 (440.29985500000004)
Pro Ile Val Ile
C22H40N4O5 (440.29985500000004)
Pro Ile Val Leu
C22H40N4O5 (440.29985500000004)
Pro Leu Ile Val
C22H40N4O5 (440.29985500000004)
Pro Leu Leu Val
C22H40N4O5 (440.29985500000004)
Pro Leu Val Ile
C22H40N4O5 (440.29985500000004)
Pro Leu Val Leu
C22H40N4O5 (440.29985500000004)
Pro Val Ile Ile
C22H40N4O5 (440.29985500000004)
Pro Val Ile Leu
C22H40N4O5 (440.29985500000004)
Pro Val Leu Ile
C22H40N4O5 (440.29985500000004)
Pro Val Leu Leu
C22H40N4O5 (440.29985500000004)
Ser His Val Val
Ser Val His Val
Ser Val Val His
Thr Ala His Ile
Thr Ala His Leu
Thr Ala Ile His
Thr Ala Leu His
Thr His Ala Ile
Thr His Ala Leu
Thr His Ile Ala
Thr His Leu Ala
Thr Ile Ala His
Thr Ile His Ala
Thr Leu Ala His
Thr Leu His Ala
Val His Ser Val
Val His Val Ser
Val Ile Ile Pro
C22H40N4O5 (440.29985500000004)
Val Ile Leu Pro
C22H40N4O5 (440.29985500000004)
Val Ile Pro Ile
C22H40N4O5 (440.29985500000004)
Val Ile Pro Leu
C22H40N4O5 (440.29985500000004)
Val Leu Ile Pro
C22H40N4O5 (440.29985500000004)
Val Leu Leu Pro
C22H40N4O5 (440.29985500000004)
Val Leu Pro Ile
C22H40N4O5 (440.29985500000004)
Val Leu Pro Leu
C22H40N4O5 (440.29985500000004)
Val Pro Ile Ile
C22H40N4O5 (440.29985500000004)
Val Pro Ile Leu
C22H40N4O5 (440.29985500000004)
Val Pro Leu Ile
C22H40N4O5 (440.29985500000004)
Val Pro Leu Leu
C22H40N4O5 (440.29985500000004)
Val Ser His Val
Val Ser Val His
Val Val His Ser
Val Val Ser His
26,26,26-trifluoro-25-hydroxy-27-norvitamin D3 / 26,26,26-trifluoro-25-hydroxy-27-norcholecalciferol
Suillin
2-Acetoxy-3-geranylgeranyl-1,4-dihydroxybenzene
26,26,26-trifluoro-25-hydroxy-27-norvitamin D3
AEE788 (NVP-AEE788)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
1-(2-(DI-TERT-BUTYLPHOSPHINO)PHENYL)-3,5-DIPHENYL-1H-PYRAZOLE
C29H33N2P (440.23812280000004)
Ifetroban
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
2,3-dehydrosimvastatin acid sodium salt
C25H37NaO5 (440.25385520000003)
2-Pyrrolidinecarboxamide, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-N-[(1S,2S)-2-hydroxy-1,2-diphenylethyl]-, (2S,4R)
C25H36N2O3Si (440.24950659999996)
14-(Nonylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol
Trans-1-[4-(4-heptylcyclohexyl)phenoxy]-2,4-dinitro benzene
Paraminabeolide D
A withanolide that is 23,26-epoxyergosta-1,4-diene substituted by a hydroxy group at position 22 and oxo groups at positions 3 and 26. Isolated from a Formosan soft coral Paraminabea acronocephala, it has been found to inhibit the accumulation of the pro-inflammatory iNOS protein.
Paraminabeolide E
A withanolide that is the C-25 epimer of paraminabeolide D. It has been isolated from a Formosan soft coral Paraminabea acronocephala.
1-Cyclohexyl-3-[1-[4-(phenylmethyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]urea
4-Methyl-pentanoic acid {1-[4-guanidino-1-(thiazole-2-carbonyl)-butylcarbamoyl]-2-methyl-propyl}-amide
L-Alfa-lysophosphatidylcholine, lauroyl
C20H43NO7P+ (440.27769980000005)
Nemiralisib
D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C78273 - Agent Affecting Respiratory System
[2-((1-OXODODECANOXY-(2-HYDROXY-3-PROPANYL))-PHOSPHONATE-OXY)-ETHYL]-TRIMETHYLAMMONIUM
C20H43NO7P+ (440.27769980000005)
(3Z)-3-[(2E)-2-[7a-methyl-1-(7,7,7-trifluoro-6-hydroxyheptan-2-yl)-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
2-[(2-Dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
N-({(2R,4S,5R)-5-[3-(3,4-Dimethoxyphenyl)-1-methyl-1H-pyrazol-5-yl]-1-azabicyclo[2.2.2]oct-2-yl}methyl)-2,2-dimethylpropanamide
N-(2-phenylethyl)-N-(phenylmethyl)-1-(3-phenylpropyl)-4-piperidinecarboxamide
3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
methyl (1R,9S,10S,11S)-12-(cyclohexanecarbonyl)-5-(cyclopenten-1-yl)-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-8-yl]-N,N-dimethylbenzamide
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
methyl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
(2R,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
1-[(2S,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2R,3S)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-phenylurea
1-[(2S,3R)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-phenylurea
1-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
1-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3-phenylurea
methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-Methoxyethyl 4-[4-(diethylamino)phenyl]-2,7,7-trimethyl-5-oxo-4,4a,6,8-tetrahydroquinoline-3-carboxylate
2-[[(2R)-2-dodecanoyloxy-3-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
2-[[(2R)-3-dodecoxy-2-methoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
N-(6-aminohexyl)-2-[anilino(phenyl)carbamoyl]-2-hydroxyhexanamide
2-[[(2R)-2-acetyloxy-3-decoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
2,3-dihydroxypropyl [2-hydroxy-3-[(Z)-tetradec-9-enoxy]propyl] hydrogen phosphate
C20H41O8P (440.25389160000003)
2-[Hydroxy-(2-hydroxy-3-tridecoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(2-Acetyloxy-3-decoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
[1-carboxy-3-[2-hydroxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]propyl]-trimethylazanium
C24H42NO6+ (440.30119720000005)
2-[(2-Hexanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(3-Acetyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(2-octanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(3-Butanoyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[(2-Butanoyloxy-3-octoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
2-[Hydroxy-(3-nonoxy-2-propanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C20H43NO7P+ (440.27769980000005)
Tirofiban
C22H36N2O5S (440.23448060000004)
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AC - Platelet aggregation inhibitors excl. heparin COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Dolichyl phosphate
C25H45O4P (440.30553000000003)
COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(5Z,7E)-(3S)-26,26,26-trifluoro-27-nor-9,10-seco-5,7,10(19)-cholestatriene-3,25-diol
TG(22:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
cPA(20:4)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved